{"protocolSection":{"identificationModule":{"nctId":"NCT05779215","orgStudyIdInfo":{"id":"XMEC-2023-002"},"organization":{"fullName":"Xuanwu Hospital, Beijing","class":"OTHER"},"briefTitle":"Registry of Acute Ischemic Stroke With Large- or Medium-vessel Occlusion","officialTitle":"The Multicenter, Prospective, Real-world Registry of Acute Ischemic Stroke With Large- or Medium-vessel Occlusion","acronym":"LOMEVO"},"statusModule":{"statusVerifiedDate":"2023-03","overallStatus":"NOT_YET_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2023-04-15","type":"ESTIMATED"},"primaryCompletionDateStruct":{"date":"2032-04-30","type":"ESTIMATED"},"completionDateStruct":{"date":"2032-12-30","type":"ESTIMATED"},"studyFirstSubmitDate":"2023-03-07","studyFirstSubmitQcDate":"2023-03-19","studyFirstPostDateStruct":{"date":"2023-03-22","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-03-19","lastUpdatePostDateStruct":{"date":"2023-03-22","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Junwei Hao, MD","investigatorTitle":"Director of Neurology Department","investigatorAffiliation":"Xuanwu Hospital, Beijing"},"leadSponsor":{"name":"Xuanwu Hospital, Beijing","class":"OTHER"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"This study is designed to observe the treatment options in real-world clinical practice as well as the safety and efficacy of different treatment strategies.","detailedDescription":"LOMEVO is a prospective, multicenter, real-world registry lasting for 10 years. A total of 50000 patients with large- or medium-vessel occlusion will be enrolled at approximately 30 centers around China."},"conditionsModule":{"conditions":["Acute Ischemic Stroke"],"keywords":["acute ischemic stroke","large vessel occlusion","medium vessel occlusion","real-world registry"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":true,"targetDuration":"90 Days","designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":50000,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"acute ischemic stroke with large- or medium-vessel occlusion","description":"acute ischemic stroke patients with large- or medium-vessel occlusion including all treatments.","interventionNames":["Other: Visit at D90"]}],"interventions":[{"type":"OTHER","name":"Visit at D90","description":"Visits at 90±7 days after stroke onset were conducted by trained and blinded investigators, with face-to-face, telephone call or Internet access.","armGroupLabels":["acute ischemic stroke with large- or medium-vessel occlusion"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"modified Rankin Scale (mRS) score","description":"Ordinal distribution of mRS at 90±7 days; modified Rankin scale (range, 0 to 6, with a score of 0 indicating no disability, 1 no clinically significant disability, 2 slight disability, 3 moderate disability but remaining able to walk unassisted, 4 moderately severe disability, 5 severe disability, and 6 death)","timeFrame":"90±7 days"}],"secondaryOutcomes":[{"measure":"Excellent functional outcome","description":"Proportion of subjects with mRS 0-1 at 90±7 days.","timeFrame":"90±7 days"},{"measure":"Good functional outcome","description":"Proportion of subjects with mRS 0-2 at 90±7 days.","timeFrame":"90±7 days"},{"measure":"mRS 0-3","description":"Proportion of subjects with mRS 0-3 at 90±7 days.","timeFrame":"90±7 days"},{"measure":"Change of National Institutes of Health Stroke Scale (NIHSS)","description":"Change of National Institutes of Health Stroke Scale (NIHSS, a scale between 0 and 42 on which higher scores indicate more severe neurologic deficits) from baseline to 24 hours.","timeFrame":"24 hours"},{"measure":"Change of National Institutes of Health Stroke Scale (NIHSS)","description":"Change of National Institutes of Health Stroke Scale (NIHSS, a scale between 0 and 42 on which higher scores indicate more severe neurologic deficits) from baseline to 7 days.","timeFrame":"7 days"},{"measure":"Symptom-to-thrombolysis time (STT)","description":"Time from onset of symptoms to thrombolytic therapy.","timeFrame":"24 hours"},{"measure":"Door-to-Needle Time (DNT)","description":"Time from the arrival of stroke patient in emergency to initiation of thrombolysis therapy.","timeFrame":"24 hours"},{"measure":"Door-to-Puncture Time (DPT)","description":"Time from the arrival of stroke patient in emergency to groin puncture.","timeFrame":"24 hours"},{"measure":"Onset-to-recanalization time","description":"Time from symptom onset to the beginning of recanalization (recanalization defined as expanded TICI scale≥2b).","timeFrame":"24 hours"},{"measure":"Door-to-Recanalization Time (DRT)","description":"Time from the arrival of stroke patient in emergency to the beginning of recanalization (recanalization defined as expanded TICI scale≥2b).","timeFrame":"24 hours"},{"measure":"Puncture-to-recanalization time","description":"Time from groin puncture to recanalization (recanalization defined as expanded TICI scale≥2b).","timeFrame":"24 hours"}],"otherOutcomes":[{"measure":"Incidence of clinically significant intracranial hemorrhage","description":"Incidence of sICH (Heidelberg criteria) measured at 36 hours","timeFrame":"36 hours"},{"measure":"Incidence of any intracranial hemorrhage","description":"Incidence of any intracranial hemorrhage (Heidelberg criteria) measured at 36 hours","timeFrame":"36 hours"},{"measure":"All-cause mortality","description":"All-cause mortality at 90±7 days","timeFrame":"90±7 days"},{"measure":"Complications related to intravenous thrombolysis","description":"Complications related to intravenous thrombolysis during hospitalization","timeFrame":"up to 7 days"},{"measure":"Complications related to endovascular treatment","description":"Complications related to intravenous thrombolysis during hospitalization","timeFrame":"up to 7 days"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* The clinical diagnosis is acute ischemic stroke with large- or medium- vessel occlusion (the criteria followed the Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018)\n* Informed consent from the patient or surrogate\n\nExclusion Criteria:\n\n* No additional exclusion criteria","healthyVolunteers":false,"sex":"ALL","stdAges":["CHILD","ADULT","OLDER_ADULT"],"studyPopulation":"Patients with acute ischemic stroke due to large- or medium-vessel occlusion will be enrolled and no additional exclusion criteria are set.","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"centralContacts":[{"name":"Junwei Hao, MD; PhD","role":"CONTACT","phone":"01083198277","email":"haojunwei@vip.163.com"},{"name":"Gaoting Ma, MD","role":"CONTACT","phone":"18301579891","email":"demo_doctor@163.com"}],"locations":[{"facility":"Xuanwu Hospital, Capital Medical University","city":"Beijing","state":"Beijing","zip":"100037","country":"China","contacts":[{"name":"Junwei Hao, MD; PhD","role":"CONTACT","phone":"01083198277","email":"haojunwei@vip.163.com"},{"name":"Gaoting Ma, MD","role":"CONTACT","phone":"18301579891","email":"demo_doctor@163.com"}],"geoPoint":{"lat":39.9075,"lon":116.39723}}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000002544","term":"Cerebral Infarction"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000007238","term":"Infarction"},{"id":"D000009336","term":"Necrosis"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","asFound":"Ischemic","relevance":"HIGH"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M9972","name":"Infarction","relevance":"LOW"},{"id":"M5483","name":"Cerebral Infarction","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}